Trademark Overview
On Monday, July 18, 2016, a trademark application was filed for ZYAMTIN with the United States Patent and Trademark Office. The USPTO has given the ZYAMTIN trademark a serial number of 87107821. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, June 5, 2017. This trademark is owned by uniQure IP B.V.. The ZYAMTIN trademark is filed in the Pharmaceutical Products category with the following description:
Biological preparations for medical use in medical and clinical gene therapy and cell therapy; clinical medical reagents for use in gene therapy, gene diagnosis, and gene testing; pharmaceutical preparations, namely, vaccines for use in gene therapy; gene therapy and prophylaxis products, namely, gene-based biological preparations and medical reagents for use in gene regulation and gene modulation for the treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, cancer, inflammatory and auto-immune diseases, vascular disorders, and single gene disorders
